leukocyte is any of the nucleated cells of the blood and lymphatic system that collectively make up the body’s cellular immune defense, distinguishing them from the anucleate erythrocyte (which transports oxygen) and the thrombocyte (platelet, which mediates clotting). All leukocytes arise from pluripotent hematopoietic stem cells in the bone marrow through the process of hematopoiesis and are broadly divided into granulocytes (neutrophils, eosinophils, basophils, containing visible cytoplasmic granules) and agranulocytes (lymphocytes and monocytes, lacking prominent granules). Leukocyte counts and behavior can be physiological, as with the transient rise seen after exercise or stress, or pathological, as with infection-driven elevation or bone marrow suppression. Clinically significant abnormalities are coded as either an elevated count, or leukocytosis (D72.82-), or a decreased count, or leukopenia (D72.81), with neutrophil-specific depletion coded separately as neutropenia (D70). Leukocyte is often confused with leukocytosis and leukopenia: leukocyte refers to the cell itself, while leukocytosis and leukopenia describe abnormal quantities of that cell in circulation.
Greek κύτος (kýtos), from Greek kytos “a hollow, vessel, receptacle"
"cell,” “hollow vessel” — noun-forming suffix used throughout modern biology and medicine to denote a cell type
The word entered English in the 1860s as leucocyte (noun), borrowed from French leucocyte, coined from Greek leukós (“white”) + kytos (“hollow vessel, cell”), literally “white cell.” The American spelling leukocyte later became standard in U.S. clinical usage, though leucocyte persists in British English. The root kytos (“cell”) connects leukocyte to the entire -cyte root family: erythrocyte (red cell → oxygen-carrying blood cell), thrombocyte (clot cell → platelet), and phagocyte (eating cell → a cell that engulfs pathogens or debris). The combining form leuko- is highly productive in medical terminology and appears in numerous other terms: leukoplakia, leukorrhea, leukemia, leukoderma.
🔀 ALIASES / ALTERNATE TERMS
Leukocytic(adjective form — used in “leukocytic infiltration,” “leukocytic response,” “leukocytic esterase reaction”)
White blood cell (WBC)(lay and clinical synonym — used interchangeably with “leukocyte” in nearly all clinical documentation and lab reporting)
Leucocyte(British/alternate spelling variant — identical meaning, used in UK and international literature)
Granulocyte(structural subtype — leukocyte containing visible cytoplasmic granules; includes neutrophils, eosinophils, and basophils)
Agranulocyte(structural subtype — leukocyte lacking prominent cytoplasmic granules; includes lymphocytes and monocytes)
Phagocyte(functional subtype — leukocyte specialized for engulfing pathogens and cellular debris; primarily neutrophils and monocytes/macrophages)
🔗 RELATED TERMS
Erythrocyte — the opposite blood cell lineage from leukocytes; an anucleate, hemoglobin-filled cell responsible for oxygen transport rather than immune defense
Thrombocyte — platelet; a non-nucleated cell fragment responsible for hemostasis and clotting, distinct from the immune function of leukocytes
Leukocytosis — abnormally elevated leukocyte count; coded under D72.82-
Leukopenia — abnormally decreased leukocyte count; coded under D72.81-
Neutropenia — specific depletion of the neutrophil subtype of leukocyte; coded under D70
Leukemia — malignant clonal proliferation of leukocyte precursors in the bone marrow, distinguished from reactive leukocytosis by clonality and blast presence
pyuria — the presence of leukocytes in urine, typically indicating urinary tract infection or inflammation; coded as R82.81
Leukocyte esterase — an enzyme produced by leukocytes and detected on urine dipstick testing as an indirect marker of pyuria
Hematopoiesis — the bone marrow process by which pluripotent stem cells differentiate into leukocytes, erythrocytes, and thrombocytes
Differential count — a laboratory test enumerating the relative percentages of each leukocyte subtype (neutrophils, lymphocytes, monocytes, eosinophils, basophils) within the total white blood cell count
CODING CORNER
🏥 ICD-10-CM CODES
Decreased White Blood Cell Count (D72.81 — Leukopenia)
Radiopharmaceutical localization of inflammatory process/tumor; whole body, requires two or more days imaging (leukocyte/WBC scan for occult infection)
⚠️ Coding Note: These leukocyte-count codes carry no laterality requirement since they describe systemic blood findings rather than an anatomic site. Sequencing logic follows the abnormal-finding rule: if a definitive underlying cause is documented (e.g., pneumonia, sepsis, chemotherapy-induced neutropenia), code the underlying condition first and the leukocyte abnormality as a secondary or manifestation code only if it affects treatment; use the D72/D70/R82 codes as primary only when no cause is identified. A frequently undercoded entry is D72.825 (Bandemia) — the documentation trigger phrase “left shift” or “bands” on a CBC differential should prompt a coder query to confirm whether bandemia is separately reportable. Payer edits commonly bundle 85025 with 85004/85027, so never bill the automated CBC-with-diff code alongside a standalone differential on the same date without modifier justification. When leukocytosis appears in the context of a possible hematologic malignancy, specificity is critical — confirm whether the documentation supports a reactive leukemoid reaction (D72.823) versus an actual leukemia diagnosis (C91-C95 category) before finalizing the code, since misclassifying a malignancy as a benign reactive process is a high-risk audit finding.